A carregar...
Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan
OBJECTIVES: In Japan, low-dose rivaroxaban [15 mg QD/10 mg QD for creatinine clearance of 30–49 mL/min] was approved for clinical use in NVAF patients partly because of its unique pharmacokinetics in Japanese subjects. The aim of the study was to determine the anticoagulation intensity of rivaroxaba...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4257912/ https://ncbi.nlm.nih.gov/pubmed/25479967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0113641 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|